
CIBCI
@kcl_cibci
News & publications from the Centre for Inflammation Biology & Cancer Immunology at Kings College London - moved to 🦋
ID: 1573264442619478017
23-09-2022 10:54:12
75 Tweet
111 Takipçi
103 Takip Edilen

And it is out! Fantastic work from Juan Carlos López-Rodríguez. MAITs, type I IFN and bacterial infection… check it out! bit.ly/3Ox5oub Journal of Experimental Medicine Thanks to our collaborators and funders Josebengoechea Biotechnology and Biological Sciences Research The Crick School of Immunology & Microbial Sciences CIBCI




If you are excited about understanding how the nervous and immune systems interact, then look no further and apply for our fantastic PhD programme Neuro-Immune Interactions in Health and Disease King's College London ! Applications welcome until Nov 13, 2023.

King's researchers highlight new potential therapies for scarring The research led by Tanya Shaw has revealed a potential therapeutic target within keloid cells which could provide new treatments for a range of skin diseases and fibrosis Read more ⬇️ kcl.ac.uk/news/kings-res…

📣The #AutoimmunityTriggers23 abstract deadline is just 2 days away! Speakers include Prof David Wraith 💙, Prof Dana Orange, Dr Pia, Prof SimonM, Prof Claudia Mauri, Prof Alberto Ascherio & Prof Ignacio Sanz 🙌 Submit by Wed 11 Oct 👉bit.ly/45mchUQ



Congrats to Sarah Sarah, Kathryn @kjasteel, and Cat Catherine Hughes CIBCI on getting their paper on synovial cytokine producing T cells in early undifferentiated inflammatory arthritis accepted in RMDOpen. Great collaboration with the Toes and Trouw labs LUMC Leiden



Presenting work from Dan Davies, Shraddha Kamdar and Immunosurveillance @TheCrick & @KingsCollegeLon

The latest Musculoskeletal Expert Patient Group blog highlights a personal view of living with Rheumatoid Arthritis and long-term pain. Dr Ruth Williams shares the importance of pain research based on her own pain experiences and other patients. mskexpertpatient.wordpress.com/2023/10/30/liv…


nature.com/articles/s4301… Pleased to share the lab’s latest work on our favourite #gdTcells and their role in cancer, out today in Nature Cancer by Dan Davies and Shraddha Kamdar and in collaboration with Immunosurveillance The Crick & King's College London. @KingsCollegeLon King's Faculty of Life Sciences & Medicine CIBCI @TheCrick


Scientists have found a drug used to treat rheumatoid arthritis could prevent the disease altogether. The drug could provide hope for half a million people with the disease. Find out more about the trial. ⬇️ King's Faculty of Life Sciences & Medicine theguardian.com/society/2024/f…

Very happy to share our latest review in our favourity molecule, CD1. Check it out! CIBCI School of Immunology & Microbial Sciences Lauren Evans CD1 molecules: Beyond antigen presentation sciencedirect.com/science/articl…



